Green Cross Holdings - ESG Rating & Company Profile powered by AI
This webpage of Green Cross Holdings was prepared by All Street Sevva using advanced machine learning. Alternative companies in the scoring industry group for Green Cross Holdings are shownin the table. The page is a zero-cost Environmental, Social and Governance analysis covering Green Cross Holdings.
Green Cross Holdings in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Green Cross Holdings | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Green Cross Holdings have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Green Cross Holdings disclose current and historical energy intensity?
Sign up for free to unlockDoes Green Cross Holdings report the average age of the workforce?
Sign up for free to unlockDoes Green Cross Holdings reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Green Cross Holdings disclose its ethnicity pay gap?
Sign up for free to unlockDoes Green Cross Holdings disclose cybersecurity risks?
Sign up for free to unlockDoes Green Cross Holdings offer flexible work?
Sign up for free to unlockDoes Green Cross Holdings have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Green Cross Holdings disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Green Cross Holdings conduct supply chain audits?
Sign up for free to unlockDoes Green Cross Holdings disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Green Cross Holdings conduct 360 degree staff reviews?
Sign up for free to unlockDoes Green Cross Holdings disclose the individual responsible for D&I?
Sign up for free to unlockDoes Green Cross Holdings disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Green Cross Holdings disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Green Cross Holdings disclose water use targets?
Sign up for free to unlockDoes Green Cross Holdings have careers partnerships with academic institutions?
Sign up for free to unlockDid Green Cross Holdings have a product recall in the last two years?
Sign up for free to unlockDoes Green Cross Holdings disclose incidents of discrimination?
Sign up for free to unlockDoes Green Cross Holdings allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Green Cross Holdings issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Green Cross Holdings disclose parental leave metrics?
Sign up for free to unlockDoes Green Cross Holdings disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Green Cross Holdings disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Green Cross Holdings disclose the pay ratio of women to men?
Sign up for free to unlockDoes Green Cross Holdings support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Green Cross Holdings disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Green Cross Holdings reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Green Cross Holdings involved in embryonic stem cell research?
Sign up for free to unlockDoes Green Cross Holdings disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Green Cross Holdings disclose its waste policy?
Sign up for free to unlockDoes Green Cross Holdings report according to TCFD requirements?
Sign up for free to unlockDoes Green Cross Holdings disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Green Cross Holdings disclose energy use targets?
Sign up for free to unlockDoes Green Cross Holdings disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Green Cross Holdings have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Green Cross Holdings
These potential risks are based on the size, segment and geographies of the company.
Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.